Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

New President and CEO of Fabege

The Board of Directors of Fabege has appointed Stefan Dahlbo as the new President and CEO. He is currently President and CEO of the listed investment company Byggmästare Anders J Ahlström Holding AB and has a long and solid experience as  CEO and board member of both listed and unlisted companies. These former board assignments include, for example, Fabege, Wihlborgs and Klövern. Stefan Dahlbo will assume his new role as soon as possible.-          We at the Board believe that Stefan Dahlbo is an excellent person to take over the leadership and development of Fabege. He knows both the real

Skanska sells 11 asphalt plants in Poland for about PLN 120 M, about SEK 300 M

Skanska has sold the majority of its asphalt operations in Poland to Colas, a member of the global group Bouygues. The value of the transaction is about PLN 120 M, about SEK 300 M, on a debt free basis. The divestment will be recorded in the second quarter 2019. The transaction will not have any material impact on the profit for the period.The asphalt plants are located in Gdańsk, Poznań, Nasławice, Zabrze, Skawina, Anielin, Warsaw, Ostaszewo, Gutkowo, Dębska Wola and Bór. The net sales in the plants reached PLN 300 M in 2018. The sale is a step in implementing Skanska’s City Builder

Vattenfall and Boliden to work together for a fossil-free future

Vattenfall AB and Boliden AB have signed a partnership agreement relating to technical development in the field of the electrification of mines and smelters, the circular economy and a fossil-free future. The agreement, which covers a four-year period, also includes battery solutions with a view to supporting the electricity grid and optimising electricity consumption.Vattenfall and Boliden are committed to the transition to a sustainable society, which means reducing dependence on fossil fuels. Under the new four-year strategic agreement, the companies will develop business solutions

BAKKAFROST: Q1 2019 Trading Update

Harvest volumes in Q1 2019 are Farming North 6.7 thousand tonnesFarming West 7.0 thousand tonnesTotal Q1 2019 13.7 thousand tonnes The harvest volumes are provided in head on gutted (HOG) equivalents. Feed sales in Q1 2019 are 16.3 thousand tonnes. Havsbrún sourced 114.0 thousand tonnes of raw materials in Q1 2019. The full Q1 2019 report will be released on 6 May 2019 at 06:00 CET. Contacts: Regin Jacobsen, CEO of P/F Bakkafrost: +298 23 50 01 (mobile) This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian

Nordic Nanovector: Promising results from preclinical studies with a novel CD37-targeted alpha therapy for B-cell tumours presented at TAT11

Oslo, Norway, 2 April 2019 Nordic Nanovector ASA (OSE: NANO) notes that promising results from its preclinical research collaboration to develop a novel CD37-targeting alpha therapy for B-cell tumours have been reported today in an oral presentation at TAT11, the 11th International Symposium on Targeted-Alpha-Therapy (1-4 April, Ottawa, Canada). The research collaboration with Orano Med (formerly known as AREVA Med) was established in June 2016 to develop and investigate a next-generation targeted alpha therapy comprising Nordic Nanovector’s chimeric anti-CD37 antibody (NNV003) and

BerGenBio: Preclinical data presented at AACR reinforces bemcentinib’s potential to reverse tumour immunosuppression and therapy resistance

· Extensive data in pre-clinical models of non-small cell lung cancer (NSCLC) and pancreatic cancer demonstrating AXL’s role in reversing tumour-mediated immunosuppression and therapy resistance presented at AACR · Selective AXL inhibitor, bemcentinib, shown to reverse AXL’s effects, thus acting synergistically with immune cells and anti-cancer therapies · Data further strengthens broad development opportunities for bemcentinib both as a monotherapy, and in combinations, in a broad spectrum of cancersBergen, Norway, 2 April 2019 – BerGenBio ASA (OSE: BGBIO) a clinical-stage

NGEX Drills 424 metres at 0.51% copper and 0.41 g/t gold and 308 metres at 0.65% copper and 0.37 g/t gold in reserve definition program at Josemaria

Vancouver, April 01, 2019 /CNW/ - NGEx Resources Inc. (TSX: NGQ) (Nasdaq Stockholm: NGQ) (“NGEx” or the “Company”) is pleased to announce initial results from this season’s reserve definition diamond drill program at its 100% owned Josemaría Project in San Juan Province, Argentina. The program was designed to increase confidence in the mineral reserve, particularly the portion scheduled for the first five years of production in the recently-completed Pre-Feasibility Study (PFS), and to provide material for feasibility-level metallurgical testwork. The program was successful and achieved

Enersize enters into new agreement with Hankook

Translation in English of previously released news: Enersize Oyj ("Enersize") today announces that the company has entered into a new agreement with Hankook Tire Jianxing Co., Ltd. ("Hankook"). The agreement is the first agreement signed regarding LEAQS in China and the first that has been signed directly with a customer in China without a partner as intermediary. The agreement concerns a pilot project of Enersize's leakage service using LEAQS in a limited part of Hankook's factory in order to show what level of energy savings can be achieved. The objective of the parties is to follow up with

Exchange rates for the first quarter of 2019

The net foreign exchange impact of the Kindred Group’s main trading currencies against its reporting currency of GBP is shown in the tables below. While this has no material impact on the underlying development of the Kindred Group’s business, it does affect the reported results when translated into GBP. The weighted average impact of GBP against the Kindred Group’s main currencies was a negative impact on Gross winnings revenue of approximately 2 per cent in the first quarter of 2019 compared to the same period of 2018. Balance sheet rates:          Rate to GBP

Stabilisation notice

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. Erik Penser Bank AB (publ) (”Erik Penser Bank”) notifies that stabilisation measures have been undertaken in Ascelia Pharma AB’s (publ) (”Ascelia Pharma” or the “Company”) shares on Nasdaq Stockholm.As announced in connection with the offering to acquire newly issued shares in the Company and the listing of the Company’s

The Swedish Tax Agency rejects Tele2’s deduction of an exchange loss

Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) has today been notified that the Swedish Tax Agency rejects a claim for a deduction of a previous exchange loss on a loan to a group company in Kazakhstan. Tele2 will appeal the decision.Tele2 has today been notified that the Swedish Tax Agency rejects Tele2’s claim for a deduction of an exchange loss related to a conversion of a shareholder loan to the group company MTS in Kazakhstan from USD to Kazakh Tenge in connection to the establishment of Tele2’s current joint venture in Kazakhstan. The additional tax claim amounts

Summons to attend the Annual General Meeting of Investment AB Latour (publ)

Summons to attend the Annual General Meeting of Investment AB Latour (publ) will be published in the Swedish Official Gazette (Post- och Inrikes Tidningar) and on the company website on Tuesday 2 April, 2019. For more information about the proposals, please refer to the full notice to the AGM below.   Summons to attend the Annual General Meeting of Investment AB Latour (publ)The shareholders in Investment AB Latour (publ) (“Latour”) are hereby summoned to attend the Annual General Meeting Tuesday 7 May 2019 5:00 p.m. at Radisson Blu Scandinavia Hotel, Södra Hamngatan 59, Göteborg,

Securitas strengthens the position within electronic security in the UK

Securitas has acquired all shares in the electronic security company Allcooper Group in the United Kingdom. Enterprise value is estimated to approximately MSEK 73 (MGBP 6).Allcooper Group, founded in 1987, specializes in the installation, maintenance and monitoring of a wide range of security and fire systems. It operates from bases in Gloucestershire, the West Midlands and London with around 100 employees and annual sales of approximately MSEK 88 (MGBP 7). Allcooper’s expertise in electronic security and its portfolio of long-term customers will provide excellent support in Securitas’

Bure’s annual report 2018

Today Bure has published the Annual Report for 2018 on its website, www.bure.se. The printed version will be distributed in the middle of April to shareholders who have ordered it. The Annual Report can be ordered by phone +46 8 614 00 20 or by e-mail info@bure.se. Bure Equity AB (publ) For more information contact: Henrik Blomquist, CEOTel.+46 (0)8 – 614 00 20 The information contained herein is subject to the disclosure requirements of Bure Equity AB (publ) under the Swedish Securities Market Act. The information was publicly communicated on 1 April 2019, 18:00 CET.

Ossur Hf : Transactions in relation to share buyback program

Announcement no. 22/2019 1 April 2019  Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share buyback program is to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy. The program will end no later than 30 June 2019. The Company may purchase up to 5,000,000 shares under the program, corresponding to 1.2% of the current share capital. The

Genombrott i USA - NewYork Presbyterian väljer DrugLog® (rättelse: i tidigare PM uteblev ordervärde, det har nu kompletterats nedan)

NewYork Presbyterian har efter omfattande utredning valt DrugLog® för att kontrollera returer av narkotiska preparat.  Avtalet omfattar totalt 5 DrugLog® enheter. Affären beräknas vara värd totalt 2 milj SEK över en tvåårsperiod. Installation kommer att ske under andra kvartalet 2019.NewYork Presbyterian (NYP), en av USA:s mest prestigefyllda sjukhuskedjor med 7 sjukhus på Manhattan i New York, har efter en omfattande utvärdering valt att beställa totalt 5 stycken DrugLog® enheter till sina anläggningar i New York. Affären beräknas vara värd totalt 2 milj SEK över en tvåårsperiod. DrugLog®

Q-FREE- ANNUAL ACCOUNTS 2018

The Board of Directors of Q-Free ASA has on 1 April 2019 approved the Directors Report and the Consolidated Financial Statements for 2018. The Consolidated Financial Statements are presented according to IFRS and will be presented for final approval at the Annual General Meeting scheduled to be held 28 May 2019. The Group's Annual Audited Consolidated Financial Statements include no material changes compared to the preliminary full year results presented 14 February 2019. The Board of Directors proposes to the Annual General Meeting that there will be no distribution of dividends for the

Changes in Lehto Group Plc's Executive Board

Stock exchange releaseLehto Group Plc1 April 2019 at 6.00 p.m.The composition of Lehto Group Plc’s Executive Board will change as of 1 April 2019. Pasi Kokko who has served as Executive Vice President, Housing, will leave Lehto Group and the Executive Board for personal reasons. He has worked for Lehto since 2013, originally as managing director of Lehto’s subsidiary in housing business and from 2017 he has been in charge of Housing service area. Lehto has started a process to recruit a new head for Housing service area. Lehto’s CEO Hannu Lehto will head the service area as long as

TELEMUNDO UNVEILS “FIRST ACT” OF “LA REINA DEL SUR” SEASON TWO FOR FANS ACROSS TELEMUNDO AND NBCUNIVERSAL PLATFORMS

The network’s most ambitious production to date, starring Kate del Castillo, premieres Monday, April 22 at 10/9C Countdown to Premiere: 21 days To view the Sneak Peek - https://youtu.be/U_rXazHVUUkMIAMI – April 1, 2019 –  Telemundo today released an exclusive First Act of the much-anticipated return of “La Reina del Sur” Season Two, starring Kate del Castillo  in her iconic role of Teresa Mendoza, which premieres on Monday, April 22 at 10pm/9C.  For the first time ever, the network will offer audiences the opportunity to view the opening act

Share buy-back by Zalaris ASA

On April 1st 2019, Zalaris ASA purchased 750 own shares on the Oslo Stock Exchange at an average price of NOK 24,0493. Following the purchase Zalaris ASA holds 192.064 own shares, representing ~0,95% of the total outstanding shares. The shares were purchased in accordance with the share buy-back programme announced 12 March 2019, available at www.newsweb.no. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

BlackRock's shareholding in UPM has gone above the threshold of 5 per cent

UPM-Kymmene Corporation     Stock Exchange Release (Flagging Release) 1 April 2019 at 17:30 EET BlackRock's shareholding in UPM has gone above the threshold of 5 per cent UPM-Kymmene Corporation has on 1 April 2019 received an announcement under Chapter 9, Section 5 of the Securities Markets Act, according to which BlackRock, Inc.'s indirect holding of UPM shares and voting rights has gone above the threshold of 5 per cent on 29 March 2019. According to the announcement, BlackRock, Inc.'s indirect shareholding in UPM has increased to 26,896,080 shares, corresponding to 5.03 per

Prof. Niek van Dijk is joining Episurf Medical’s Clinical Advisory Board

Episurf Medical AB (NASDAQ: EPIS B) is expanding its Clinical Advisory Board with the addition of Prof. Niek van Dijk. Prof. van Dijk is a leading authority for foot and ankle surgery globally and he has treated people across the world, including several leading athletes.    Prof. van Dijk is professor in orthopaedic surgery at the University of Amsterdam and he is the former head of the Orthopaedic Department of the AMC (Academic Medical Center) hospital in Amsterdam. He is currently working in the FIFA Medical Centres of Excellence in Madrid, Clinic Ripoll, de Prado & van Dijk (near

Decisions taken by Avidly Plc’s Annual General Meeting and Board of Directors

Avidly Plc, Company Announcement, 1 Apr 2019 at 17:00 EET Decisions taken by Avidly Plc’s Annual General Meeting and Board of Directors The Annual General Meeting (AGM) of Avidly Plc was held on 1 April 2019 in Helsinki. The AGM adopted the Financial Statements including the consolidated financial statement, the Board of Directors’ Report and the Auditor’s Report for the year 2018 and discharged the members of the Board of Directors and the CEO from liability. The AGM resolved to pay dividend of EUR 0.08 per share. Use of profit and payment of dividend The AGM resolved,

Total Voting Rights

1 April 2019 15:00 BST Transparency Directive Voting Rights and Capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 31 March 2019 the issued share capital of AstraZeneca PLC with voting rights is 1,267,368,885 ordinary shares of US$0.25. No shares are held in Treasury. Therefore, the total number of voting rights in AstraZeneca PLC is 1,267,368,885. The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they

There are no items matching the current filter
There are no more items matching the current filter
Back to top